Junctional sequences created by chromosomal translocations in mature B-cell neoplasms, which involve immunoglobulin gene loci (IC) and putative proto-oncogenes on reciprocal partner chromosomes, are unique to neoplastic cells characterized by particular histological and immunological phenotypes. To establish a rapid and sensitive method to detect neoplastic cells carrying a specific chromosomal translocation. we have developed a novel strategy based on long-distance polymerase chain reaction (LD-PCR) amplification. Genomic DNA was extracted from tumor cells carrying t(14; 19)(q32;q13), t(8; 14)(q24;q32), t(3;22)(@7;qll), t(2;3)(p12;q27), or t(3;14)(q27;q32). Thirty-two to 35-mer oligonucleotide primer pairs were designed to be complementary to exons or flanking sequences of the 6CL3, c-MYC and 6CL6 oncogmes, and to IG constant region genes. LD-PCR with a newly available Taq polymerase for longer product synthesis successfully amplified fragments representing BCWIca! junctional sequences for t(1419); c-MYCICp, c-UMAN LEUKEMIAS and lymphomas are often asso-H ciated with specific chromosomal translocations that correlate closely with particular histological and immunological phenotypes.' Many of the genes located on the breakpoints of these recurring translocations have been cloned, and it has been shown that chromosomal translocation leads to the formation of fusion genes encoding chimeric proteins with unique biochemical properties or to alterations in expression of the genes.' Because the junctional sequences created by the fusion of two genes are specific to particular subtypes of leukemias and lymphomas, detection of these sequences provides valuable information for diagnosis and subsequent management of hematological neoplasms. Translocations in acute leukemias and chronic myelocytic leukemia result in production of fusion transcripts that contain information from two genes involved in the transl~cation.~ These fusion transcripts can be easily detected by reverse transcriptase (RT)-mediated polymerase chain reaction (PCR) amplification," although the amplified fragments are not unique to individual patients.
Junctional sequences created by chromosomal translocations in mature B-cell neoplasms, which involve immunoglobulin gene loci (IC) and putative proto-oncogenes on reciprocal partner chromosomes, are unique to neoplastic cells characterized by particular histological and immunological phenotypes. To establish a rapid and sensitive method to detect neoplastic cells carrying a specific chromosomal translocation. we have developed a novel strategy based on long-distance polymerase chain reaction (LD-PCR) amplification. Genomic DNA was extracted from tumor cells carrying t(14; 19)(q32;q13), t(8; 14)(q24;q32), t(3;22)(@7;qll), t(2;3)(p12;q27), or t(3;14)(q27;q32). Thirty-two to 35-mer oligonucleotide primer pairs were designed to be complementary to exons or flanking sequences of the 6CL3, c-MYC and 6CL6 oncogmes, and to IG constant region genes. LD-PCR with a newly available Taq polymerase for longer product synthesis successfully amplified fragments representing BCWIca! junctional sequences for t(1419); c-MYCICp, c-UMAN LEUKEMIAS and lymphomas are often asso-H ciated with specific chromosomal translocations that correlate closely with particular histological and immunological phenotypes.' Many of the genes located on the breakpoints of these recurring translocations have been cloned, and it has been shown that chromosomal translocation leads to the formation of fusion genes encoding chimeric proteins with unique biochemical properties or to alterations in expression of the genes.' Because the junctional sequences created by the fusion of two genes are specific to particular subtypes of leukemias and lymphomas, detection of these sequences provides valuable information for diagnosis and subsequent management of hematological neoplasms. Translocations in acute leukemias and chronic myelocytic leukemia result in production of fusion transcripts that contain information from two genes involved in the transl~cation.~ These fusion transcripts can be easily detected by reverse transcriptase (RT)-mediated polymerase chain reaction (PCR) amplification," although the amplified fragments are not unique to individual patients.
In contrast, many of the translocations in mature B-cell neoplasms involve immunoglobulin gene (IC) loci and, in general, coding regions of the putative oncogenes on partner chromosomes are not interrupted by the translocation. The overall consequence of these translocations appears to be inappropriate levels of oncogene product compared with normal lymphocytes at the equivalent stage of B-cell differentiati~n.~ Thus, targets for PCR amplification in B-cell neoplasms are single-copy junctional sequences of translocations within complex genomic DNA. A generally applicable example of PCR detection of junctional sequences is t( 14; 18)(q32; q21) transl~cation.~ Tight clustering of the breakpoints at two main regions of the BCL2 gene and the availability of consensus sequences of the J segments of IC heavy chain gene ( E H ) make this a particularly favorable target for PCR amplification to detect lymphoma cells containing the translocation. However, PCR amplification in other B-cell tumor-associated translocations has not yet been MYC/Cy, and c-MYC/Cru for t (8;14) ; BCLG/CX for t (3;22) ; BCLG/CK for t(2;3); 5'-6CLG/Cp. and 5'-6CL6/Cy for t (3; 14) . In Burkitt's lymphoma/leukemia. all materials in which c-MYC rearrangements were detectable by conventional Southern blot hybridization showed positive LD-PCR amplification. The sizes of the amplified fragments varied from 1.8 kb to 12 kb, and these were specific to each material. Serial dilution of tumor cells or DNA in negative materials demonstrated a single band on agarose gel electrophoresis stained with ethidium bromide at a level of sensitivity of and hybridization with radioactive probe improved the level by one order of magnitude (1 cell in lo'), indicating that this LD-PCR approach is a sensitive technique capable of detecting minimal residual disease. Thus, the present study provided a useful tool for diagnosis and subsequent management of B-cell neoplasms characterized by specific chromosomal translocations. 0 7 9 9 6 by The Americsn Society of Hematology.
established, as the breakpoint on the partner chromosome can be distributed over a large region,6 such that the region enclosed by the primers is too large to yield a PCR product by standard PCR techniques, and because breakage of the IGH gene sometimes occurs in switch regions composed of repeat sequences,' making it difficult to design unique primers immediately adjacent to breakpoints.
Recently, Taq DNA polymerase for PCR amplification has been improved for longer product synthesis, and effective amplification of long targets from human genomic DNA has been described.' In this study, we designed specific oligonucleotide primer pairs complementary to exons or flanking sequences of the c-MYC, BCL2, BCL3, and BCM oncogenes and to constant region genes of the IG genes. We present here a novel strategy for detection of the junctional sequences of translocations in mature B-cell neoplasms, based on long-986 AKASAKA ET AL distance (LD)-PCR amplification using a newly available Tuq DNA polymerase.
MATERIALS AND METHODS
Involved lymph node tissues or other tumor samples from patients with lymphoid neoplasms were studied by routine cytological and histological review, immunohistochemical analysis, immunological phenotyping, and antigen receptor gene rearrangement analysis to determine B-cell origin. Cell lines used in this study were as follows: Burkitt's lymphoma/leukemia (BL) cell lines Ramos, Manca, Raji, Daudi, and P3HR-1 were characterized previously by other investigators'-' '; KS-Bu3, DL-4, Kobayashi, L-1091, IT0,I2 Kimura, KPB-L2,l3 Middle91, Tree92, and Black93 lines were established and characterized in our laboratory; HBL-4 and HBL-5I4 were provided by Dr M. Abe (Fukushima Prefectural University of Medicine, Fukushima, Japan); BW-1 was obtained from Dr T. Tsuda (Wakayama Prefectural University of Medicine, Wakayama, Japan); and MD901I5 was from Dr T. Miki (Tokyo Medical and Dental University School of Medicine, Tokyo, Japan). The cell lines were maintained in RPMI 1640 medium supplemented with 10% fetal calf serum and antibiotics at 37°C in 5% CO2. Cytogenetic analysis was performed for cell lines and selected tumor materials.
DNA probes for oncogenes involved in translocations were as follows: pal.4P probe for the BCL3 geneI6; F372 probe representing the major translocation cluster (MTC) region of the BCM geneI7; and pMyc6514-1 (exon 1) and pMyc6514-2 (exon 2) probes for the c-MYC gene, which were provided by the Japanese Cancer Research Resources Bank (JCRB; Tokyo, Japan). DNA probes for the IG genes were as described previo~sly.~ Genomic DNA extracted from tumor materials and cell lines was analyzed with regard to rearrangement of oncogenes by Southem blot analysis. DNA was digested with restriction enzymes, electrophoresed through 0.8% agarose gels, and transferred onto nylon membrane filters (Genescreen Plus; NEN Research Products, Boston, MA). The membranes were hybridized with probes labeled with [a-32P]dCTP (3,000 Ci/mmol, Amersham, Arlington Heights, IL), using a random primer labeling system (Amersham, Buckinghamshire, UK). Hybridization and washing conditions were as recommended by the manufacturer.
EBV nuclear antigen was detected by the method of Reedman and Klein.I8 In selected materials, the presence of EBV genome was determined by Southem blot hybridization with a DNA probe including the terminal repeats." The DNA used as a probe was provided by Dr K. Hirai (Tokyo Medical and Dental University School of Medicine, Tokyo, Japan).
Genomic DNA was digested with an appropriate restriction enzyme, and ligated into BumHI sites of the XDAS-HI1 bacteriophage vector (Stratagene, La Jolla, CA). The ligated DNA was packaged in vitro with the Gigapack Gold system (Stratagene). Approximately 1 X 10' phage clones of the genomic DNA library were screened by plaque hybridization. DNA from the isolated phage clones was purified (QIAGEN lambda kit), and DNA fragments of interest were further subcloned into pBluescript I1 SK(+) (Stratagene).
The sequences and site specificities of each primer are listed in Table 1 . Primers for oncogenes were designed to be complementary to exons or flanking sequences located outside of the breakpoints. Primers for the IG genes represented constant region genes from three IG loci. These primers were composed of 32 to 35 oligonucleotides except for MYC/06. OLIGO software (National Bioscience, Inc, Plymouth, MN) was used to evaluate secondary priming sites, and inter-and intraprimer complementation.
Genomic DNA and bacteriophage DNA were precipitated with Tumor materials and cell lines.
DNA probes and genomic Southern blot hybridization.
Detection of Epstein-Barr virus (EBV).

Molecular cloning.
Oligonucleotide primers and PCR. 
RESULTS
Reliability of LD-PCR amplijication.
To establish reaction conditions and to evaluate the reliability of LD-PCR amplification, we first performed reactions using isolated clones as templates, and the most suitable primer pair and optimal conditions for efficient PCR amplification of the junctional sequences were defined. These reaction conditions were then used for LD-PCR on genomic DNA.
pIM8.4G plasmid clone ( Fig 1A) was isolated from a patient with chronic lymphocytic leukemia characterized by rearrangement of the BCL3 gene." The clone included the BCL3 sequences on chromosome 19, which were joined to the 5' side of the switch region of the Am(2) allotype of the Ca2 constant gene.*' The breakpoint on chromosome 19 was 0.8 kb upstream of the first exon of BCL3. Thus, the clone represented junctional sequences of the t( 14; 19) translocation, although cytogenetic data were not available. AMH-1 phage clone (Fig 1B) was isolated from a patient with highgrade small noncleaved cell lymphoma (no. 744; this patient was reported as case 2 in Ohno'* and case 8 in Ohno"). The lymphoma cells had a t(3; 22)(q27;ql1) translocation and the BCL6 gene on chromosome band 3q27 was rearranged with the IGA light chain gene. Restriction mapping of the clone showed that chromosome 3 sequences were joined to the 5' side of the third constant region gene of the IGA gene (Ch3).24 The breakpoint on chromosome 3 was within the MTC region of the BCL6 geneI7 and that on chromosome 22 presumably occurred at the J segment associated with the CA3 constant gene.
The t(14; 19) translocation involved the S a switch region composed of regular pentamer repeat sequences, hindering the design of primers capable of specific hybridization to this particular region. Thus, we prepared a primer for the chromosome 14 sequences to be hybridized with the CH1 exon of the C a constant gene,2' which is located downstream of the S a switch region. Oligonucleotide primers for the chromosome 19 sequences were designed to be complemen- tary to the sequences of the 5' flanking region of the BCL3 gene?6 Although breakpoints of the 3q27 translocations have been reported to occur within the 10 kb MTC region, variability of the breakpoints can be great at the nucleotide level from case to case. Thus, to develop a generally applicable method for detection of the translocations, we designed primer pairs that were complementary to the second exon of the BCM gene:' located downstream of the MTC and coding sequences of the CA constant region gene?4 Because recombination between the two genes affected by these translocations occurred in divergent orientation, the primers represented antisense sequences in reverse directions.
PCR amplification was performed using a newly available Tuq polymerase, which was improved to allow amplification of longer fragments. Figure 2A shows the results of LD-PCR amplification using the cloned and genomic DNA as templates. LD-PCR analysis detected a 1.8-kb fragment representing the 5'-BCW/Ca junction in t(14; 19) and a IO-kb discrete single band representing the BCM/Ch junction in t(3;22). The sizes of the PCR product from the genomic DNA were identical to those from the cloned DNA, as expected from the restriction maps of the clones. To confirm amplification, the amplified fragments were transferred onto nylon membranes and hybridized with the appropriate radiolabeled probes; strong hybridization with the probes was observed (Fig 2B) . These pilot studies clearly demonstrated For intron, leaving the coding regions of c-MYC. composed of the second and third exons, intact. We thus designed primers for the second exon of the c-MYC gene (MYC/04)2X and constant region genes of the prepared; one for the membrane exon (CylOI) and the other for the CH I exon (Cy/02). The former was located approximately 3.5 kb downstream of the latter. Orientation of the primer pairs was the same as that described for t( 14; 19) and t (3;22) . Figure 4A shows the results of LD-PCR for BL cell lines, in which the genomic structures of t(8; 14) have been well IGH.?>.?%j? For the Cy gene, two independent primers were Fig 3A, LD-PCR using appropriate primer pairs successfully detected c-MYCIIGH fusions in these cell lines. The sizes of the amplified fragments were compatible with those expected from the reported genomic structures.
We next applied the LD-PCR approach to large numbers of established cell lines and fresh tumor materials from cases pMyc(S14-2 of BL. All materials were subjected to LD-PCR using the primers for the c-MYC exon 2 (MYC/04) and four IGH constant gene loci. Table 2 summarizes the results in BL cells with some of their properties. Figure 4B shows a representative EtBr-stained gel; specific amplification were confirmed by hybridization with a DNA probe (pMyc6514-2) representing the c-MYC exon 2 and an oligonucleotide probe (MYC/06) for the c-MYC sequence internal to the PCR primer. Figure 5 shows a negative amplification study of LD-PCR for c-MYCIIGH junction in BL and other hematological tumor cell lines in which no c-MYC rearrangement with IGH gene was apparent on genomic Southern blot hybridization. (Fig 1B) .
Daudi and P3HR-I, which carried a t(8; 14) translocation
We performed LD-PCR amplification on genomic DNAs, in which rearrangement of the BCM gene was determined by Southern blot hybridization with the MTC probe. Of 34 materials examined, eight fresh materials and one cell line were positive for amplification (Fig 6, Table 3 ). The BCM/ CA junctional products from two patients, including one (no. 744) described above, and MD901 cell line were similar in size, suggesting that breakage and joining in these three samples occurred at similar positions on the two genes. The amplified product representing t(2;3) was detected in a patient who carried both B C U and BCM gene rearrangements. Primer pairs for the 5'-BCM and IGH constant genes successfully amplified fragments including a junction of t(3; 14) from five cases; two had a 5'BCM/Cp junction and three had a 5'-BCM/Cy junction, respectively.
Sensitivity of LD-PCR. To test the sensitivity of LD-
PCR amplification, we performed a serial dilution mixing experiment with genomic DNA from Kobayashi cells carrying a c-MYCIC y junction and unrelated human DNA. The experiment consistently demonstrated a single band on agarose gel electrophoresis stained with EtBr at the level of sensitivity of Hybridization with a radiolabeled probe improved the level of sensitivity by one order of magnitude (Fig 7A) . To mirror the clinical conditions, Kimura cells, which also carried a c-MYCICy junction, were diluted with increasing proportions of lymphoblastoid cells established from a normal subject, and DNA was extracted from each dilution. As shown in Fig 7B, the sensitivity of was confirmed in this experiment. As 100 ng of DNA is the equivalent of IO4 cells on average, the present LD-PCR method was capable of detecting a single copy of the cMYCllGH junction.
DISCUSSION
Because malignant lymphoma is a disease curable by appropriate treatment, the ability to detect lymphomatous infiltration is important not only for accurate staging of the disease at presentation, but also for the evaluation of therapy. Considerable effort has been made to develop newer, more sensitive techniques capable of detecting minimal residual disease (MRD), which is almost certainly the source of recurring disease. The PCR technique, which specifically amplifies DNA sequences of interest, has greatly increased the sensitivity of MRD dete~tion.~' Because the vast majority of B-cell neoplasms are characterized by clonal rearrangement of the IGH gene, PCR amplification of unique sequences of the complementarity-determining region 111 (CDRIII) of the IGH, which was originally developed for detection of B-cell lineage acute lymphoblastic leukemia,'R has been applied to mature B-cell neoplasm^.'^ However, one of the potential problems of the application of CDRIII amplification to malignant lymphoma is that the PCR product may not represent a neoplastic clone, as lymphoma tissues are apparently composed of heterogeneous cell populations in addition to neoplastic cells. Another disadvantage of this PCR approach is the occurrence of clonal changes within this particular region during the course of the disease, potentially leading to false negative amplification in tumor tissue obtained at relapse.".@
In contrast to the CDRIII sequences, junctional sequences created by chromosomal translocations in B-cell neoplasms, which involve IG loci and cellular oncogenes on the reciprocal partner chromosome, are unique to lymphoma cells characterized with particular histological and immunological phenotypes. Moreover, the junctional sequences would be stable during the course of the disease, as the fusion of two genes is most likely critical for the malignant phenotype. Thus, detection of these sequences provides valuable information for diagnosis and subsequent management of B-cell neoplasms. Here, we have described a sensitive method to detect lymphoma cells characterized by chromosomal translocation using a novel strategy based on long distance PCR amplification, as well as specific primer pairs for two genes involved in the translocation. The PCR strategy apparently circumvents problems in standard PCR techniques, ie, difficulty in design of unique primers adjacent to breakpoints on IG genes and distribution of breakpoints over a large region on the reciprocal partner chromosome. Other advantages of this LD-PCR approach are that it can be applied to translocations in which the DNA sequences of the regions immediately adjacent to the breakpoint have not yet heen defined, and that amplified fragments have sequences unique to individual patients. Thus, this PCR approach could be applied to analysis of translocations in leukemias; PCR using DNA is considerably easier than RT-PCR, which requires RNA isolation and cDNA synthesis.
During the past decade, an increasing number of centers have treated patients with malignant lymphoma on first remission with high-dose myeloablative therapy and autologous hematopoietic stem cell support.4' It is generally accepted that patient selection is a major factor in determining the disease-free survival in this trial. Diffuse large cell lymphoma (DLCL) of B-cell phenotype constitutes 30% to 40% of adult non-Hodgkin's lymphoma4' and is a good candidate for this aggressive treatment. Thus, sensitive genetic markers for assessment of MRD of this particular lymphoma subtype are urgently required. Association of 3q27 translocations with DLCL have been and t(8; 14) has been observed not only in BL, but also in DLCL; Offit et al" showed that t(8; 14) is the second and t(3;22) is the third most common translocation in this lymphoma subtype. Thus, the present PCR strategy should be useful for determining the efficiency of experimental approaches such as in vitro purging of grafts for transplantation obtained from autologous bone m a r~o w~~ or peripheral blood stem cell collections, which have been performed for lymphoma carrying the t(14; 18) translocation. It would be of interest to determine whether patients with PCR-detectable disease ultimately relapse. The present study provided a potentially useful tool for further understanding of the contribution of MRD to subsequent relapse of malignant lymphoma.
The translocation t (8; 14) differs at the molecular level in endemic and sporadic cases of BL.6 Breakpoints in endemic tumors lie far 5' of the c-MYC gene and involve the DH and JH segments of the IGH. In contrast, translocations in sporadic cases occur at a point close to the c-MYC exon 1 and within switch regions of the IGH. The LD-FCR approach is apparently capable of detecting translocations of the sporadic type. In the present study, all cell lines and tumor materials in which c-MYC rearrangements were detectable by conventional Southern blot analysis were positive for amplification. Thus, it is evident that the current LD-PCR approach is an important adjunct to time-consuming Southern hybridization. It has been suggested that t(8; 14) probably occurs in sporadic cases at a later stage of B-cell differentiation where the machinery for isotype class switching is Our present study showed an unexpected higher frequency of involvement of the y and a gene loci than of the p gene, confirming further the correlation between t(8; 14) and the class switch mechanism.
The 3q27 translocation affecting the BCL6 gene is unique in that it can involve not only the IG loci, but also other partner chromosomes.17~23~43 In this study, nine of 34 (26.5%) materials with a BCL6 gene rearrangement were positive for amplification, indicative of recombination with the IG loci.
However, two materials with a cytogenetically identified translocation with chromosomal loci for the IGH and the IGK genes lacked fragments amplifiable by the present LD-PCR method (data not shown). Thus, the proportion of the involvement of IG loci in 3q27 translocations could be underestimated. It is of interest to determine whether breakpoints on the IG genes in the negative cases were at uncharacterized loci, which could be unrelated to known constant genes, or translocations generated sequences, which could prevent polymerase activity. Further improvement of primer design and reaction conditions will be necessary to elucidate this point.
Deweindt et al," cloned a complicated junctional sequence of t(3; 14) from a patient with non-Hodgkin's lymphoma. They showed that chromosome 3 materials were translocated to an inverted 14q32 V,-containing fragment, which was itself translocated to the JH segment; the BCM coding regions joined the IGH gene in divergent orientation. In the present study, however, we observed no head-to-head fusion of BCL6 exon 2 with the IGH, as expected from the observations reported by Deweindt et al, even in cases with t(3; 14) on cytogenetic analysis. Because the BCL6 gene lies in telomere-to-centromere orientation on chromosome 3, t(3;14) would result in juxtaposition of 5'-BCL6 with the IGH on the 14q+ chromosome and junction of the VDJ complex-containing IGH segment with the coding exons of the BCM on the 3q-c h r o m o~o m e~~ Our LD-PCR study using primer pairs for the 5'-BCL6 and IGH constant genes provided persuasive evidence of this recombination on 14q+. This molecular consequence is in contrast with that of other translocations involving the IGH gene; coding regions are invariably juxtaposed with the downstream sequences of IGH, including a second enhancer located 3' of the C02 gene." Thus, it is possible that the critical molecular consequence of the 3q27 translocations may be the deletion of the first exon and 5' regulatory element, leading to enhanced expression. Of course, this does not exclude the possibility of transcriptional activity in the VDJ-containing segment of the IGH gene.
